1. Jacquet P, Vidal-Jove J, Zhu BW, Sugarbaker PH. Peritoneal carcinomatosis from intraabdominal malignancy: natural history and new prospects for management. Acta Chir Belg (in press).
2. Sugarbaker PH, Graves T, DeBruijn EA,et al. Rationale for early postoperative intraperitoneal chemotherapy (EPIC) in patients with advanced gastrointestinal cancer. Cancer Res 1990;50:5790–4.
3. Sugarbaker PH, Graves T, Sweatman TW. Early postoperative intraperitoneal adriamycin. Pharmacologic studies and a preliminary clinical report. Reg Cancer Treat 1991;4:127–31.
4. Sugarbaker PH, Cunliffe WJ, Belliveau JF,et al. Rationale for integrating early postoperative intraperitoneal chemotherapy (EPIC) into the surgical treatment of gastrointestinal cancer. Semin Oncol 1989;16:83–97.
5. Eggermont AM, Steller EP, Marquet RL, Jeekel J, Sugarbaker PH. Local promotion of tumor growth after abdominal surgery is dominant over immunotherapy with interleukin-2 and lymphokine activated killer cells. Cancer Detect Prev 1988;12:421–9.